[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100479236":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":31,"centralContacts":35,"locations":45,"responsibleParty":61,"collaborators":64,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":39,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":39,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":90,"overallStatus":47,"whyStopped":39,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"University of Washington","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Neurologic Disorders","EXPERIMENTAL","Evaluation of individual and combined effects of mobility devices and spinal stimulation for individuals with neurologic disorders.",[13,14],"Device: Mobility Device","Device: Spinal Stimulation",[16,25],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DEVICE","Mobility Device","Use of mobility device during session.",[9],[22,23,24],"Biomotum SPARK","Trexo","Portable Mobility Aid for Children (PUMA, ENLITEN)",{"type":17,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"Spinal Stimulation","A stimulator will be used non-invasively stimulate the spine at the neck and\u002For lower back (cervical and\u002For lum",[9],[30],"SpineX",[32],{"name":33,"affiliation":5,"role":34},"Katherine Steele, PHD","PRINCIPAL_INVESTIGATOR",[36,41],{"name":33,"role":37,"phone":38,"phoneExt":39,"email":40},"CONTACT","206-685-2390",null,"kmsteele@uw.edu",{"name":42,"role":37,"phone":43,"phoneExt":39,"email":44},"Katie Landwehr, MS","937-231-1205","klandweh@uw.edu",[46],{"facility":5,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"RECRUITING","Seattle","Washington","98195","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-122.33207,47.60621,{"lat":57,"lon":56},[60],{"name":42,"role":37,"phone":43,"phoneExt":39,"email":44},{"type":34,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":39,"oldOrganization":39},"Katherine Steele","Professor, Mechanical Engineering",[65],{"name":66,"class":6},"Seattle Children's Hospital","100479236","spinal-stimulation-and-mobility-devices-100479236",false,"NCT05520359","Spinal Stimulation and Mobility Devices","Transcutaneous Stimulation and Mobility Device Use for Individuals With Neurologic Conditions","Inclusion Criteria:\n\n* have a neurologic condition\n* are 4-70 years of age\n* have stable medical condition\n* can perform simple cued motor tasks and who can follow 2-3 step commands\n* who are volunteering to be involved in this study\n* can provide feedback on comfort and experience during lab visits\n\nExclusion Criteria:\n\n* have significant medical disease; including uncontrolled systemic hypertension with values above 170\u002F100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation.\n* have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention\n* have a history of uncontrolled seizures\n* have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities\n* are dependent on ventilation support\n* have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)\n* have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months\n* have established osteoporosis and taking medication for osteoporosis treatment.\n* have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)\n* have active cancer","ALL","4 Years","70 Years",{"count":78,"type":79},20,"ESTIMATED","INTERVENTIONAL",[82],"NA","This research study will combine non-invasive spinal stimulation with mobility devices to examine the acute impact of the individual and combined effects of these innovative techniques on mobility in children with cerebral palsy.",[85,86,87,88,89],"Cerebral Palsy","Stroke","Premature Birth","Hypoxic-Ischemic Encephalopathy","Periventricular Leukomalacia",[91,92,93,26],"Pediatric","Mobility Aids","Assistive Technology","2025-08-11",{"date":96,"type":97},"2025-08-13","ACTUAL",{"date":99,"type":97},"2022-08-04",{"date":101,"type":79},"2026-12-31",{"name":5,"class":6},1]